Related Experiment Video
Updated: Jun 11, 2025

10:40
Measuring Neuromuscular Junction Functionality
Published on: August 6, 2017
17.9K
Skeletal Muscle Involvement in Friedreich Ataxia
Elisabetta Indelicato1, Julia Wanschitz2, Wolfgang Löscher2
1Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
International Journal of Molecular Sciences
|September 28, 2024
Summary
Friedreich Ataxia (FRDA) involves skeletal muscle damage driven by mitochondrial dysfunction. Investigating muscle in FRDA is crucial for developing biomarkers and new therapies.
Area of Science:
- Neurology
- Mitochondrial Biology
- Genetics
Background:
- Friedreich Ataxia (FRDA) is an inherited neuromuscular disorder caused by frataxin deficiency.
- Frataxin deficit impairs mitochondrial function, leading to cellular energy deficits.
- Clinical manifestations include neurological deficits and cardiac/skeletal muscle involvement.
Purpose of the Study:
- To review skeletal muscle findings in Friedreich Ataxia.
- To explore the role of mitochondrial damage in FRDA skeletal muscle pathology.
- To highlight the importance of skeletal muscle research for FRDA therapeutic development.
Main Methods:
- Review of functional imaging studies in FRDA.
- Analysis of histological findings in FRDA skeletal muscle.
- Integration of multiomics data from FRDA models and patients.
Main Results:
- Evidence confirms a distinct disease phenotype in FRDA skeletal muscle.
- Progressive mitochondrial damage is identified as a key driver of FRDA progression.
- Skeletal muscle involvement contributes to weakness and fatigue in FRDA patients.
Conclusions:
- Skeletal muscle is significantly affected in Friedreich Ataxia.
- Mitochondrial dysfunction is central to FRDA skeletal muscle pathology.
- Skeletal muscle investigations are vital for developing FRDA biomarkers and therapies.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Disorders of the Skeletal Muscle
903
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
903
Myasthenia Gravis: Diagnostic Tests
692
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
692
Cross-bridge Cycle
117.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.0K
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K

